Patient preferences for treatment of chronic rhinosinusitis with nasal polyps
Volume: 0 - Issue: 0
First page: 0 - Last page: 0
J. Sutphin - S. Okafor - S.D. Reed - A. Deb - J. Silver - M.J. Wallace - J.-C. Yang - R. Abi Hachem - D.W. Jang
DOI: 10.4193/Rhin24.475
Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient preferences. Currently, there are no quantitative studies investigating patient preferences for CRSwNP treatment options. Increased awareness of patient-centered approaches to treatment warrant further investigation.
Rhinology 0-0: 0-0, 0000
To see the issue content and the abstract you do not have to login
Please login to download the full articles
If you do not have a subscription to Rhinology please consider taking one.
